Journal Publishes ZUSDURI Trial Results

The Journal of Urology has published the pivotal ENVISION trial results for ZUSDURI, showing a 72.2% duration of response at 24 months. UroGen announced the online publication of these significant findings. The data demonstrates ZUSDURI's sustained efficacy over a two-year period, marking a key milestone in the drug's development and potential therapeutic application. This publication validates the drug's performance in a peer-reviewed medical journal.